Interventional Pulmonology Market 2022
The global Interventional Pulmonology Market is estimated at a CAGR of 4% by the year 2021-2031. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period.
Interventional pulmonology is an area of pulmonary medicine that deals specifically with minimally invasive endoscopic and percutaneous procedures for the diagnosis and treatment of neoplastic as well as non-neoplastic diseases of the airways, lungs, and pleura. Rise in the number of COPD cases across the world is expected to boost demand over the coming years.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12544
Need for faster recovery time and reduced pain during procedures and surgeries for respiratory disorders has strengthened the market. Leading manufacturers of interventional pulmonology devices are focusing on geographical expansion to increase revenue and add new repair and service centers in emerging countries through the acquisition of local players.
Various awareness programs have been initiated by healthcare providers and health organizations/societies such as environmental programs, medication maintenance programs, and online education programs for public and healthcare professionals across the globe to control asthma, COPD, and other respiratory diseases. Major companies such as Boston Scientific Corporation, Olympus Corporation, and FUJIFILM Corporation, besides others, are focused on spreading awareness regarding respiratory diseases.
As per Persistence Market Research analysis, the global interventional pulmonology market is expected to exhibit a CAGR of more than 4% over the forecast period (2021 – 2031).
Company Profiles:
- Medtronic Plc
- Boston Scientific Corporation
- Olympus Corporation
- FUJIFILM Corporation
- Becton, Dickinson and Company
- Smiths Group Plc
- Cook Medical
- Vygon
- Clarus Medical LLC
- Huger Medical Instrument Co. Ltd
- Taewoong Medical Co. Ltd.
- Shanghai AoHua Photoelectricity Endoscope Co., Ltd
- Karl Storz
- Richard Wolf Corporation
- PENTAX Medical
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12544
Key Takeaways from Study
- IP diagnostic devices are expected to hold maximum revenue share under products.
- Lung cancer is projected to be the dominant segment among indications, in terms of revenue. The segment accounted for 26.6% share in 2020.
- The U.S., followed by Europe, is expected to hold substantial revenue share in the global interventional pulmonology market.
- Emerging economies such as China, India, Brazil, Mexico, and South Africa have a large COPD patient pool, and rising disposable income of patients with increased healthcare expenditure would encourage interventional pulmonology device manufacturers to enter these markets.
- The interventional pulmonology space faced adverse effects due to the COVID-19 crisis as a result of supply chain disruptions and economic impact of the pandemic on small- and medium-sized enterprises.
- Hospitals and diagnostic centers to account for bulk of the market share (around ¾).
“Rising global prevalence of various respiratory diseases has increased demand for effective diagnosis and treatment in order to better manage the progression rate of these diseases,” says a Persistence Market Research analyst.
Acquisitions of Small & Medium Players – Imperative Strategy for Market Players
Given the consolidation in the market, bigger players are focusing on the acquisition of small and medium market players. This trend is being observed across North America and Europe. This is dominated by players with a strong regional distribution presence in terms of direct sales force and medical ventilator product manufacturing.
What else is in the report?
Persistence Market Research offers actionable insights and unique perspective on the interventional pulmonology market in its latest study, presenting historical demand assessment of 2016 – 2019 and projections for 2021–2031, based on product (Electromagnetic Navigation Bronchoscopy (ENB), IP Diagnostic Devices, IP therapeutic devices), indication (Asthma, Lung Cancer, COPD, Foreign Body Extraction, Tracheal and Bronchial Stenosis), and end user (Hospitals, Pulmonology Clinics, Ambulatory Surgical Centers, Diagnostic Centers), across seven key regions of the world.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/12544
Key Questions Answered in the Interventional Pulmonology Market Report
How is the Interventional Pulmonology Market expected to grow over the projected period?
What direction is the Interventional Pulmonology Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Interventional Pulmonology Market in future?
What are the key market drivers in the Interventional Pulmonology Market?
What are significant opportunities and improvement areas for Interventional Pulmonology Market manufacturers?
What are the key developments and trends taking over the Interventional Pulmonology Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Interventional Pulmonology Market?
If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.
About Us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com